In several cancers such as pancreatic ductal adenocarcinoma, cholangiocarcinoma, cancer of the ovary, bladder cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma, and BC, SPRY4‐IT1 hinders cell death while empowering cell development and tumor proliferation [148]. Here, SPRY4 is linked to breast cancer.